Finally, Western analysis showed that JQ1 abrogate phosphorylation of ERK1/2 and AKT, suggesting that the anti‐tumour effect of BRD inhibition in venetoclax‐resistant cells could depend on an impairment of this protein activity (Figure 4G). The gene discussed is AKT1; the disease is neoplasm.